The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Coding Corner Answer: How to Bill a Rituximab Infusion Visit?

Coding Corner Answer: How to Bill a Rituximab Infusion Visit?

April 16, 2019 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Take the challenge.

You Might Also Like
  • Coding Corner Question: How to Bill a Rituximab Infusion Visit?
  • Coding Corner Answer
  • Rheumatology Coding Corner Answer: Billing for an Inflectra Infusion
Explore This Issue
April 2019
Also By This Author
  • Systematically Improve Practice Operations Performance

CPT Codes: 96413, 96415 x 3, J9312 x 5, 96375, J2920

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Diagnoses: M05.79

Coding Rationale

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As of Jan. 1, 2019, the Healthcare Common Procedure Coding System (HCPCS) code for rituximab was changed from J9310 rituximab 100 mg, to the new HCPCS code J9312 (injection, rituximab, 100 mg). According to a Verywell Health article written on Dec. 28, 2017, many patients have an adverse reaction to this drug, ranging from mild to major. This usually occurs within the first hour of the infusion; therefore, the infusion is administered as a slow drip to minimize any reaction to the rituximab.

Note: The saline is not billable because it was used in the infusion and included in the Relative Value Unit (RVU) of the reimbursement for the infusion. CPT code 96365 is billed twice for the methylprednisolone sodium succinate (J2920).

The ICD-10 diagnostic code M05.79 is for rheumatoid arthritis of multiple sites, rheumatoid factor positive, without organ or systems involvement.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

For questions or additional information on coding and documentation guidelines, contact Melesia Tillman, CPC-I, CPC, CRHC, CHA, via email at [email protected] or call 404-633-3777 x820.

Editor’s note: This article was updated on April 25, 2019, to correct two of the CPT codes in the answer.

Filed Under: Billing/Coding, From the College, Rheumatoid Arthritis Tagged With: Infusion, rituximabIssue: April 2019

You Might Also Like:
  • Coding Corner Question: How to Bill a Rituximab Infusion Visit?
  • Coding Corner Answer
  • Rheumatology Coding Corner Answer: Billing for an Inflectra Infusion
  • Rheumatology Coding Corner Answer: Billing Infusion Procedure with JW Modifier

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)